224 related articles for article (PubMed ID: 19837822)
1. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
[TBL] [Abstract][Full Text] [Related]
2. Human rhinovirus infection during naturally occurring COPD exacerbations.
George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
[TBL] [Abstract][Full Text] [Related]
3. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
[TBL] [Abstract][Full Text] [Related]
4. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
5. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.
Quint JK; Donaldson GC; Wassef N; Hurst JR; Thomas M; Wedzicha JA
BMC Pulm Med; 2012 Jun; 12():28. PubMed ID: 22726649
[TBL] [Abstract][Full Text] [Related]
6. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
[TBL] [Abstract][Full Text] [Related]
7. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
Roland M; Bhowmik A; Sapsford RJ; Seemungal TA; Jeffries DJ; Warner TD; Wedzicha JA
Thorax; 2001 Jan; 56(1):30-5. PubMed ID: 11120901
[TBL] [Abstract][Full Text] [Related]
8. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.
Denlinger LC; Sorkness RL; Lee WM; Evans MD; Wolff MJ; Mathur SK; Crisafi GM; Gaworski KL; Pappas TE; Vrtis RF; Kelly EA; Gern JE; Jarjour NN
Am J Respir Crit Care Med; 2011 Nov; 184(9):1007-14. PubMed ID: 21816938
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the detection rate and load of rhinovirus in nasal versus lower airway samples from patients with chronic obstructive pulmonary disease].
Liao H; Chen R; Guan W; Yang Z; Liu W; Zhou R; Zhong N
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):21-3. PubMed ID: 24694969
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
[TBL] [Abstract][Full Text] [Related]
11. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection.
Spurrell JC; Wiehler S; Zaheer RS; Sanders SP; Proud D
Am J Physiol Lung Cell Mol Physiol; 2005 Jul; 289(1):L85-95. PubMed ID: 15764644
[TBL] [Abstract][Full Text] [Related]
12. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
[TBL] [Abstract][Full Text] [Related]
13. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
14. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive biomarkers in exacerbations of obstructive lung disease.
Warwick G; Thomas PS; Yates DH
Respirology; 2013 Jul; 18(5):874-84. PubMed ID: 23521049
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
17. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
[TBL] [Abstract][Full Text] [Related]
18. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
Bhowmik A; Seemungal TA; Sapsford RJ; Wedzicha JA
Thorax; 2000 Feb; 55(2):114-20. PubMed ID: 10639527
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with symptomatic rhinovirus infection in patients with COPD.
Gandhi A; Walsh EE; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Baran A; Falsey AR
J Clin Virol; 2012 Dec; 55(4):343-7. PubMed ID: 22999488
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sampling methods for the detection of human rhinovirus RNA.
Waris M; Österback R; Lahti E; Vuorinen T; Ruuskanen O; Peltola V
J Clin Virol; 2013 Sep; 58(1):200-4. PubMed ID: 23810645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
